Proc Natl Acad Sci U S A 2005, 102:15533–15538.PubMedCrossRef 18. Glatt SJ, Stone WS, Nossova N, Liew CC, Seidman LJ, Tsuang MT: Similarities and differences in peripheral blood gene-expression signatures of individuals with schizophrenia and their first-degree biological relatives. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:869–887.PubMed 19. Wang HY, Sun BY, Zhu ZH, Chang ET, To KF, Hwang JS, Jiang H, Kam MK, Chen G, Cheah SL, Lee M, Liu ZW, Chen J, Zhang JX, Zhang HZ, He JH, Chen FL, Zhu XD, Huang MY,
Liao DZ, Fu J, Shao Q, Cai MB, Du ZM, Yan LX, Hu CF, Ng HK, Wee JT, Qian CN, Liu Q, Ernberg I, Ye W, Adami HO, Chan AT, Zeng YX, Shao JY: Eight-signature classifier for prediction of nasopharyngeal carcinoma survival. J Clin
Oncol 2011, 29:4516–4525.PubMedCrossRef 20. Akutsu N, Bastien Y, Lin R, Mader S, White JH: Amphiregulin is a vitamin D3 target gene selleck products in squamous cell and breast carcinoma. Biochem Biophys Res Commun 2001, 281:1051–1056.PubMedCrossRef 21. Bankovic J, Stojsic J, Jovanovic D, Andjelkovic T, Milinkovic V, Ruzdijic S, Tanic N: Identification of genes NVP-HSP990 order associated with non-small-cell lung cancer promotion and progression. Lung Cancer 2010, 67:151–159.PubMedCrossRef 22. Heisel SM, Ketter R, Keller A, Klein V, Pallasch CP, Lenhof HP, Meese E: Increased seroreactivity to glioma-expressed antigen 2 in brain tumor patients under radiation. PLoS One 2008, 3:e2164.PubMedCrossRef 23. Nishii Y, Morishima M, selleck chemicals llc Kakehi Y, Umehara K, Kioka N, Terano Y, Amachi T, Ueda K: CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated Tenoxicam from cisplatin-resistant cell line. FEBS Lett 2000, 465:153–156.PubMedCrossRef 24. Umehara H, Nishii Y, Morishima M, Kakehi Y, Kioka
N, Amachi T, Koizumi J, Hagiwara M, Ueda K: Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A. Biochem Biophys Res Commun 2003, 301:324–329.PubMedCrossRef 25. Xie SM, Fang WY, Liu TF, Yao KT, Zhong XY: Association of ABCC2 and CDDP-resistance in two sublines resistant to CDDP derived from a human nasopharyngeal carcinoma cell line. J Oncol 2010, 915046:7. 26. Florea AM, Büsselberg D: Cisplatin as an Anti-Tumor Drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers 2011, 3:1351–1371.CrossRef 27. Kurosaki T, Shinohara H, Baba Y: B cell signaling and fate decision. Annu Rev Immunol 2010, 28:21–55.PubMedCrossRef Competing interests Chun Ren Lim, Chin Wei Bong, Michelle Mei Lin Lee, Jian Jiek Ooi, David Suria, Samuel Chao, Hengxuan Yang and Choong-Chin Liew are all employed by GeneNews Limited, who sponsored this research. Choong-Chin Liew is Chief Scientist of GeneNews and also holds stock in the company. None of the other authors has any conflict of interest.